Immediate Impact
38 standout
Citing Papers
Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Arteid Memaj being referenced
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142
2022 Standout
Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients (Pts) with advanced hepatocellular carcinoma (aHCC): Long-term results from CheckMate 040.
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Arteid Memaj | 198 | 56 | 14 | 102 | 69 | 17 | 267 | |
| Qiaoqi Sui | 203 | 81 | 6 | 74 | 60 | 20 | 269 | |
| Benjamin Bonhomme | 125 | 42 | 24 | 45 | 78 | 15 | 249 | |
| Aseem Lal | 142 | 144 | 12 | 77 | 78 | 17 | 309 | |
| Sang Hoon Ji | 196 | 99 | 9 | 63 | 154 | 15 | 308 | |
| Estelle Cauchin | 126 | 86 | 12 | 85 | 62 | 19 | 225 | |
| Konstantinos Papadimitriou | 135 | 71 | 12 | 39 | 59 | 22 | 262 | |
| Sara Hafezi‐Bakhtiari | 131 | 85 | 19 | 88 | 85 | 24 | 258 | |
| F. Bacci | 101 | 45 | 14 | 103 | 60 | 13 | 242 | |
| Yoshifuku Nakayama | 111 | 97 | 5 | 84 | 70 | 23 | 289 | |
| Christiana Brenin | 118 | 95 | 6 | 46 | 116 | 15 | 274 |
All Works
Loading papers...